Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: |
Title | Squarex |
Description | Clinical Trials Sign A clinical stage pharmaceutical company developing a topical formulation of the immunomodulator squaric acid dibutyl ester for the prevention of recurrent cold sores (herpes labialis) and other infections caused by Herpes Simplex Virus 1 or Herpes |
Keywords | N/A |
WebSite | squarex-pharma.com |
Host IP | 198.71.232.3 |
Location | United States |
Site | Rank |
US$3,664,491
Last updated: 2023-05-10 21:58:50
squarex-pharma.com has Semrush global rank of 2,888,342. squarex-pharma.com has an estimated worth of US$ 3,664,491, based on its estimated Ads revenue. squarex-pharma.com receives approximately 422,826 unique visitors each day. Its web server is located in United States, with IP address 198.71.232.3. According to SiteAdvisor, squarex-pharma.com is safe to visit. |
Purchase/Sale Value | US$3,664,491 |
Daily Ads Revenue | US$3,383 |
Monthly Ads Revenue | US$101,479 |
Yearly Ads Revenue | US$1,217,739 |
Daily Unique Visitors | 28,189 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
squarex-pharma.com. | A | 600 | IP: 198.71.232.3 |
squarex-pharma.com. | NS | 3600 | NS Record: ns30.domaincontrol.com. |
squarex-pharma.com. | NS | 3600 | NS Record: ns29.domaincontrol.com. |
squarex-pharma.com. | MX | 3600 | MX Record: 0 squarexpharma-com01i.mail.protection.outlook.com. |
squarex-pharma.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
Home About Us About Us Management Contact US Clinical Trials Clinical Trials Clinical Trials Sign Up Patents More Home About Us About Us Management Contact US Clinical Trials Clinical Trials Clinical Trials Sign Up Patents Home About Us About Us Management Contact US Clinical Trials Clinical Trials Clinical Trials Sign Up Patents More than 50 million people in the U.S suffer from painful, embarrassing and itchy cold sores—yet there are no existing medications to prevent outbreaks, and the products that treat patients after an outbreak aren’t very effective. We believe there is a better way to manage cold sore outbreaks–prevention. Our lead product candidate, SQX770, has the potential to be the first approved therapeutic for cold sore prevention. SQX770 is a topical formulation applied to the arm using a band-aid type patch for a few hours, with convenient dosing any time during or between outbreaks. SquareX’s clinical trials have demonstrated that one dose improves immune response to |
HTTP/1.1 301 Moved Permanently location: https://squarex-pharma.com/ Vary: Accept-Encoding Server: DPS/1.12.0 X-SiteId: 2000 Set-Cookie: dps_site_id=2000; path=/ Date: Wed, 03 Nov 2021 12:57:14 GMT Connection: keep-alive Keep-Alive: timeout=5 HTTP/2 404 content-type: text/html;charset=utf-8 content-length: 964 vary: Accept-Encoding server: DPS/1.12.0 x-siteid: 2000 set-cookie: dps_site_id=2000; path=/; secure date: Wed, 03 Nov 2021 12:57:14 GMT |
Domain Name: SQUAREX-PHARMA.COM Registry Domain ID: 1952502791_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-08-12T19:54:25Z Creation Date: 2015-08-11T23:59:59Z Registry Expiry Date: 2023-08-11T23:59:59Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS29.DOMAINCONTROL.COM Name Server: NS30.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-10-06T12:38:15Z <<< |